Can Blood Biomarkers Help Predicting Outcome in Transcatheter Aortic Valve Implantation?
Transcatheter aortic valve implantation (TAVI) has become the method of choice for patients with severe aortic valve stenosis, who are ineligible or at high risk for surgery. In this high risk patient population, early and late mortality and rehospitalization rates after TAVI are still relatively hi...
Main Authors: | Cécile Oury, Alain Nchimi, Patrizio Lancellotti, Jutta Bergler-Klein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fcvm.2018.00031/full |
Similar Items
-
Editorial: From Biology to Clinical Management: An Update on Aortic Valve Disease
by: Cécile Oury, et al.
Published: (2019-01-01) -
Transapical transcatheter aortic valve implantation: The Berlin experience
by: D'ancona Giuseppe, et al.
Published: (2012-01-01) -
Transcatheter Aortic Valve Implantation: Our Experience and Review of the Literature
by: Nedim Soydan, et al.
Published: (2012-06-01) -
Predicting Disease Progression and Mortality in Aortic Stenosis: A Systematic Review of Imaging Biomarkers and Meta-Analysis
by: Alain Nchimi, et al.
Published: (2018-08-01) -
Transcatheter aortic valve implantation under conscious sedation – the first Indian experience
by: Syed Maqbool, et al.
Published: (2014-03-01)